1. Home
  2. ARAI vs CELU Comparison

ARAI vs CELU Comparison

Compare ARAI & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ARAI

Arrive AI Inc.

HOLD

Current Price

$0.88

Market Cap

35.0M

Sector

Finance

ML Signal

HOLD

Logo Celularity Inc.

CELU

Celularity Inc.

HOLD

Current Price

$1.29

Market Cap

36.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARAI
CELU
Founded
2020
2016
Country
United States
United States
Employees
N/A
123
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.0M
36.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ARAI
CELU
Price
$0.88
$1.29
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$12.00
$6.00
AVG Volume (30 Days)
209.6K
101.3K
Earning Date
11-14-2025
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$900.00
$76.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.74
$1.01
52 Week High
$15.50
$4.35

Technical Indicators

Market Signals
Indicator
ARAI
CELU
Relative Strength Index (RSI) 39.37 54.82
Support Level N/A $1.25
Resistance Level $1.13 $1.33
Average True Range (ATR) 0.10 0.07
MACD 0.03 0.01
Stochastic Oscillator 36.35 81.08

Price Performance

Historical Comparison
ARAI
CELU

About ARAI Arrive AI Inc.

Arrive AI Inc is a technology company. Its patented Autonomous Last Mile (ALM) platform enables secure, efficient delivery to and from a smart, AI-powered mailbox-whether by drone, ground robot, or human courier. The platform provides real-time tracking, smart logistics alerts, and advanced chain-of-custody controls to support shippers, delivery services, and autonomous networks. By combining artificial intelligence with autonomous technology, Arrive AI makes the exchange of goods between people, robots, and drones frictionless and convenient. Its system integrates with smart home devices such as doorbells, lighting, and security systems to streamline the entire last-mile delivery experience.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: